Search
for
Sort by
Research 961–990 of 1000+
- Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome
- Vaccines, adjuvants and autoimmunity
- The Rotterdam Study: 2012 objectives and design update
- The Rotterdam Study: 2010 objectives and design update
- Chemical Composition and Biological Activities of Essential Oils of Curcuma Species
- Prostaglandin D <sub>2</sub> Inhibits Hair Growth and Is Elevated in Bald Scalp of Men with Androgenetic Alopecia
- Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study
- Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions
- Essential Oils and Their Single Compounds in Cosmetics—A Critical Review
- Seaweeds as Source of Bioactive Substances and Skin Care Therapy—Cosmeceuticals, Algotheraphy, and Thalassotherapy
- Wound Healing and the Use of Medicinal Plants
- WNT Signaling in Disease
- Autoimmunity: Alopecia Areata
- A Perspective on RNAi-Based Biopesticides
- Genetic architecture of mouse skin inflammation and tumour susceptibility
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- The use of cyclosporine in dermatology: Part I
- Chitosan-Based Hemostatic Hydrogels: The Concept, Mechanism, Application, and Prospects
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Regulatory T Cells: the Many Faces of Foxp3
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- TRP Channels in Skin Biology and Pathophysiology
- Endocannabinoids limit excessive mast cell maturation and activation in human skin
- Netherton's syndrome: A syndrome of elevated IgE and characteristic skin and hair findings
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- The Skin Microbiome: Current Landscape and Future Opportunities
- Long-Term Effects of COVID-19
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Advances in Chitosan-Based Nanoparticles for Drug Delivery